📋
What this means for you
AI-generated plain English summary
✓
What this means**: The health authorities stopped reviewing a new medicine called brensocatib that was being considered to help teenagers and adults with a lung condition called bronchiectasis (a disease that damages the airways). The review didn't finish, so this medicine is not available through the health system right now.
✓
What you should do**: If you have bronchiectasis and were hoping to use this medicine, talk to your doctor about other treatment options that are available to help manage your condition. Your doctor can discuss what treatments might work best for you.
✓
Key takeaway**: Just because this medicine's review was stopped doesn't mean there are no treatments for bronchiectasis—your healthcare team can help you find other ways to manage your lung health.
Always speak to your doctor before making any changes to your health or treatment.
New Guidance: NICE
View official guidance ↗
View official guidance ↗
TA1188
📋 What this means for you: Speak to your GP or specialist to understand how this guidance affects your care.
Read full article on NICE ↗
This article summarises content originally published by NICE. PatientIQ provides independent plain English summaries.